SCHEMBL4597101

SCHEMBL4597101

CC(=O)OC1C=CC=CO1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30425410 0.87
SCHEMBL11548380 0.78 CA12 (0.33)
SCHEMBL11550661 0.78 CA12 (0.33)
SCHEMBL20695063 0.78
SCHEMBL8880906 0.76
SCHEMBL30586002 0.75 NAAA (0.32)
SCHEMBL340771 0.75
SCHEMBL5838798 0.75
Bicarbonate SCHEMBL9447127 0.72
SCHEMBL10430863 0.72 ALDH1A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024115355-A1 CONJUGATES OF POLYSACCHARIDES AND HYDROPHOBIC COMPOUNDS AS EMULSION STABILIZERS BASF SE (DE) 2024-06-06 WO disclosed
WO-2024038046-A1 PROCESS FOR PRODUCING MICROPARTICLES BASF SE (DE) 2024-02-22 WO disclosed
US-20230390167-A1 PROCESS FOR PRODUCING MICROPARTICLES LADEN WITH AN AROMA CHEMICAL BASF SE (DE) 2023-12-07 US disclosed
EP-4236908-A1 PROCESS FOR PRODUCING MICROPARTICLES LADEN WITH AN AROMA CHEMICAL BASF SE (DE) 2023-09-06 EP disclosed
US-20230044427-A1 EVAPORATION RETARDANT MEMBRANE FOR ODORANT COMPOSITIONS BASF SE (DE) 2023-02-09 US disclosed
US-11471397-B2 Process for the preparation of microcapsules FIRMENICH SA (CH) 2022-10-18 US disclosed
CN-115003342-A Evaporation-retarding film for odorant composition 巴斯夫欧洲公司 2022-09-02 CN disclosed
EP-3996660-A1 PROCESS FOR PRODUCING MICROPARTICLES LADEN WITH A VOLATILE ORGANIC ACTIVE BASF SE (DE) 2022-05-18 EP disclosed
WO-2022090460-A1 PROCESS FOR PRODUCING MICROPARTICLES LADEN WITH AN AROMA CHEMICAL BASF SE (DE) 2022-05-05 WO disclosed
CN-114096234-A Method for producing microparticles loaded with volatile organic active 巴斯夫欧洲公司 2022-02-25 CN disclosed
US-20180044313-A1 METHOD FOR PRODUCING TETRAHYDROPYRANYL ESTERS BASF SE (DE) 2018-02-15 US disclosed
WO-2018019894-A1 PROCESS FOR THE PREPARATION OF MICROCAPSULES FIRMENICH SA (CH) 2018-02-01 WO disclosed
US-20170292084-A1 USE OF ISOMERICALLY PURE OR HIGHLY ISOMER-ENRICHED CIS- OR TRANS-(2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL)ACETATE BASF SE (DE) 2017-10-12 US disclosed
EP-3197987-A1 USE OF ISOMERICALLY PURE OR HIGHLY ISOMER-ENRICHED CIS- OR TRANS-(2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL)ACETATE BASF SE (DE) 2017-08-02 EP disclosed
WO-2016046360-A1 USE OF ISOMERICALLY PURE OR HIGHLY ISOMER-ENRICHED CIS- OR TRANS-(2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL)ACETATE BASF SE (DE) 2016-03-31 WO disclosed
EP-1874723-A2 NEW NITROGENATED TRANS-STILBENE ANALOGS, METHOD FOR THE OBTENTION AND MEDICAL APPLICATIONS THEREOF Dominion Pharmakine S.L. (ES) 2008-01-09 EP disclosed
WO-2006108864-A2 NEW NITROGENATED TRANS-STILBENE ANALOGS, METHOD FOR THE OBTENTION AND MEDICAL APPLICATIONS THEREOF DOMINION PHARMAKINE S.L. (ES) 2006-10-19 WO disclosed
EP-0383446-B1 2,4,4-Trisubstituted tetrahydropyranyl esters and organoleptic uses thereof INT FLAVORS & FRAGRANCES INC (US) 1995-05-03 EP disclosed
US-4963285-A 2,4,4-irisubstituted tetrahydro pyranyl esters and organoleptic uses thereof INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1990-10-16 US disclosed
EP-0383446-A2 2,4,4-Trisubstituted tetrahydropyranyl esters and organoleptic uses thereof INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1990-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044313-A1 METHOD FOR PRODUCING TETRAHYDROPYRANYL ESTERS DHPS, DHCR7, CYP4A11 POLB 4242/4885
US-20230390167-A1 PROCESS FOR PRODUCING MICROPARTICLES LADEN WITH AN AROMA CHEMICAL AUP1, CHMP4B, EXOSC9 POLB 393/4885
US-20170292084-A1 USE OF ISOMERICALLY PURE OR HIGHLY ISOMER-ENRICHED CIS- OR TRANS-(2-ISOBUTYL-4-METHYL-TETRAHYDROPYRAN-4-YL)ACETATE HPD, ACMSD, TES POLB 2562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.